FogPharma announced the addition of two people to its executive leadership team, with Dr. Lihua Yu joining as chief data officer and Dr. Keither Orford as chief medical officer and EVP of clinical and translational science. Yu previously served as president and chief data science officer at H3 Biomedicine, and Orford previously led clinical development as chief medical officer at Calithera Biosciences.

“Lihua and Keith are accomplished drug development executives and we are excited to welcome them to our growing leadership team,” Gregory Verdine, founder and CEO at FogPharma, said in a statement. “Keith and Lihua will be critical to our future successes as we continue to scale.”